A New Approach to
Kidney Health

Nearly 1.2 million Medicare Advantage members have undiagnosed chronic kidney disease (CKD), a major cost driver for payers. 

Although a simple urine test can provide an early warning for the disease during its early asymptomatic stages, the albumin-to-creatinine ratio (ACR) test rates for at-risk people are as low as 20%.

As a result, many Americans are unaware of the problem and miss the opportunity for earlier, life-saving interventions. 

Download this white paper to learn how smartphone-powered, at-home kidney health testing can:

• increase compliance rates for ACR testing
• improve clinical outcomes for patients 
• reduce kidney care costs for health plans